Editorial: Toward Personalized Treatment for Systemic Juvenile Idiopathic Arthritis

doi:10.1002/art.40501

Editorial

. 2018 Aug;70(8):1172-1174.

doi: 10.1002/art.40501. Epub 2018 Jun 29.

Editorial: Toward Personalized Treatment for Systemic Juvenile Idiopathic Arthritis

Sebastiaan J Vastert¹, Peter A Nigrovic²

Affiliations

¹ University Medical Center Utrecht, Utrecht, The Netherlands.
² Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

PMID: 29569852
PMCID: PMC6105394
DOI: 10.1002/art.40501

Editorial

Editorial: Toward Personalized Treatment for Systemic Juvenile Idiopathic Arthritis

Sebastiaan J Vastert et al. Arthritis Rheumatol. 2018 Aug.

. 2018 Aug;70(8):1172-1174.

doi: 10.1002/art.40501. Epub 2018 Jun 29.

Authors

Sebastiaan J Vastert¹, Peter A Nigrovic²

Affiliations

¹ University Medical Center Utrecht, Utrecht, The Netherlands.
² Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

PMID: 29569852
PMCID: PMC6105394
DOI: 10.1002/art.40501

No abstract available

PubMed Disclaimer

Comment on

IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis.
Arthur VL, Shuldiner E, Remmers EF, Hinks A, Grom AA, Foell D, Martini A, Gattorno M, Özen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Oliveira S, Yeung RSM, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rösen-Wolff A, Minden K, Szymanski AM; INCHARGE Consortium; Thomson W, Kastner DL, Woo P, Ombrello MJ. Arthur VL, et al. Arthritis Rheumatol. 2018 Aug;70(8):1319-1330. doi: 10.1002/art.40498. Epub 2018 Jun 28. Arthritis Rheumatol. 2018. PMID: 29609200 Free PMC article.

Cited by

Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial.
Kedor C, Listing J, Zernicke J, Weiß A, Behrens F, Blank N, Henes JC, Kekow J, Rubbert-Roth A, Schulze-Koops H, Seipelt E, Specker C, Feist E. Kedor C, et al. Ann Rheum Dis. 2020 Aug;79(8):1090-1097. doi: 10.1136/annrheumdis-2020-217155. Epub 2020 May 13. Ann Rheum Dis. 2020. PMID: 32404342 Free PMC article. Clinical Trial.
Costs of Hospital-Associated Care for Patients With Juvenile Idiopathic Arthritis in the Dutch Health Care System.
Kip MMA, de Roock S, van den Berg I, Currie G, Marshall DA, Grazziotin LR, Twilt M, Yeung RSM, Benseler SM, Vastert SJ, Wulffraat N, Swart JF, IJzerman MJ. Kip MMA, et al. Arthritis Care Res (Hoboken). 2022 Oct;74(10):1585-1592. doi: 10.1002/acr.24621. Epub 2022 Jul 7. Arthritis Care Res (Hoboken). 2022. PMID: 33938161 Free PMC article.
Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: a real-world data analysis.
Kip MMA, de Roock S, Currie G, Marshall DA, Grazziotin LR, Twilt M, Yeung RSM, Benseler SM, Vastert SJ, Wulffraat N, Swart JF, IJzerman MJ. Kip MMA, et al. Rheumatology (Oxford). 2023 Feb 23;62(SI2):SI170-SI180. doi: 10.1093/rheumatology/keac299. Rheumatology (Oxford). 2023. PMID: 35583252 Free PMC article.

References

1. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med. 2005;201:1479–1486. - PMC - PubMed
1. Nigrovic PA, Mannion M, Zeft AS, Rabinovich EC, Rossum MAJVan, Cortis E, et al. Anakinra as first-line disease modifying therapy in systemic juvenile idiopathic arthritis report of 46 patients from an international multicenter series. Arthritis Rheum. 2010;62:209. Available at: http://www.embase.com/search/results?subaction=viewrecord&from=export&id.... - PubMed
1. Vastert SJ, Jager W, de Noordman BJ, Holzinger D, Kuis W, Prakken BJ, et al. Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study. Arthritis Rheumatol. 2014;66:1034–1043. Available at: http://doi.wiley.com/10.1002/art.38296. - DOI - PubMed
1. Nigrovic PA. Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis? Arthritis Rheumatol (Hoboken, NJ) 2014;66:1405–1413. - PubMed
1. Benedetti FDe, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367:2385–95. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23252525. - PubMed

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med. 2005;201:1479–1486. - PMC - PubMed

[2] Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med. 2005;201:1479–1486. - PMC - PubMed

[3] Nigrovic PA, Mannion M, Zeft AS, Rabinovich EC, Rossum MAJVan, Cortis E, et al. Anakinra as first-line disease modifying therapy in systemic juvenile idiopathic arthritis report of 46 patients from an international multicenter series. Arthritis Rheum. 2010;62:209. Available at: http://www.embase.com/search/results?subaction=viewrecord&from=export&id.... - PubMed

[4] Nigrovic PA, Mannion M, Zeft AS, Rabinovich EC, Rossum MAJVan, Cortis E, et al. Anakinra as first-line disease modifying therapy in systemic juvenile idiopathic arthritis report of 46 patients from an international multicenter series. Arthritis Rheum. 2010;62:209. Available at: http://www.embase.com/search/results?subaction=viewrecord&from=export&id.... - PubMed

[5] Vastert SJ, Jager W, de Noordman BJ, Holzinger D, Kuis W, Prakken BJ, et al. Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study. Arthritis Rheumatol. 2014;66:1034–1043. Available at: http://doi.wiley.com/10.1002/art.38296. - DOI - PubMed

[6] Vastert SJ, Jager W, de Noordman BJ, Holzinger D, Kuis W, Prakken BJ, et al. Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study. Arthritis Rheumatol. 2014;66:1034–1043. Available at: http://doi.wiley.com/10.1002/art.38296. - DOI - PubMed

[7] Nigrovic PA. Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis? Arthritis Rheumatol (Hoboken, NJ) 2014;66:1405–1413. - PubMed

[8] Nigrovic PA. Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis? Arthritis Rheumatol (Hoboken, NJ) 2014;66:1405–1413. - PubMed

[9] Benedetti FDe, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367:2385–95. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23252525. - PubMed

[10] Benedetti FDe, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367:2385–95. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23252525. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Editorial: Toward Personalized Treatment for Systemic Juvenile Idiopathic Arthritis

Affiliations

Editorial: Toward Personalized Treatment for Systemic Juvenile Idiopathic Arthritis

Authors

Affiliations

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical